title: High-dose intensity regimens with epirubicin in ovarian cancer.
authors.affiliation: Department of Oncology, Free University Hospital, Amsterdam, The Netherlands.
authors.forename: J B
authors.initials: JB
authors.lastname: Vermorken
authors.forename: G
authors.initials: G
authors.lastname: Bolis
authors.forename: R E
authors.initials: RE
authors.lastname: van Rijswijk
authors.forename: A
authors.initials: A
authors.lastname: Kobierska
authors.forename: B
authors.initials: B
authors.lastname: Chevallier
authors.forename: M E
authors.initials: ME
authors.lastname: van der Burg
authors.forename: F
authors.initials: F
authors.lastname: Zanaboni
authors.forename: M A
authors.initials: MA
authors.lastname: Lentz
authors.forename: C W
authors.initials: CW
authors.lastname: Burger
authors.forename: P
authors.initials: P
authors.lastname: Kenemans
mesh_terms: D002945:Cisplatin / Q000008:administration & dosage / Q000009:adverse effects; D015251:Epirubicin / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D016178:Granulocyte-Macrophage Colony-Stimulating Factor / Q000627:therapeutic use; D006801:Humans; D010051:Ovarian Neoplasms / Q000188:drug therapy*
chemical_list: D015251:Epirubicin; D016178:Granulocyte-Macrophage Colony-Stimulating Factor; D002945:Cisplatin